Market Research

Active Pharmaceutical Ingredients (API) Market

Best Price Guarantee Length Publisher Published Date SKU
from $4,500 310 Pages Coherent Market Insights September, 2023 CMI18238050
Best Price Guarantee
Price from $4,500
Length 310 Pages
Publisher Coherent Market Insights
Published Date September, 2023
SKU CMI18238050

Active Pharmaceutical Ingredients (API) Market, By Product Type (Low Potent APIs, High Potent APIs), By Molecular Type (Small Molecules, Large Molecules), By Formulation (Oral, Topical, Injectables, Drops), By Application (Diabetes, Oncology, Cardiovascular, CNS, Analgesics, Ophthalmic, Respiratory, Dermatology, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Active pharmaceutical ingredients (APIs) and excipients are the two most important components in the production of a medication. API is the raw material that is used in manufacturing medications, whereas an excipient is a substance that functions as a medium to help the body absorb the drug, such as lactose or mineral oil in a tablet. Active pharmaceutical ingredients are produced by using highly technological industrial processes, both during the research and development and commercial production phases. Such compounds are developed to provide pharmacological activity or other direct impacts on disease diagnosis, cure, mitigation, therapy, or prevention, or to change the structure and function of the body. The growth of the active pharmaceutical ingredients (API) market can be attributed to certain factors, such as increasing funding initiatives by the government across different regions. For instance, in May 2020, the U.S. Department of Health and Human Services (HHS) announced that it will provide funding of US$ 354 million to Phlow Corporation, a pharmaceutical company, under a four-year contract to produce the active pharmaceutical ingredientss (APIs) needed for medications to treat patients with COVID-19 and related illnesses.

Market Dynamics

The rising U.S. Food and Drug Administration (FDA) approvals for drugs by pharmaceutical companies are further expected to boost the global active pharmaceutical ingredients (API) market growth during the forecast period. For instance, in December 2020, Eily Lilly, an American pharmaceutical company received U.S FDA clearance for several medicines, including increased dosages of its Trulicity therapy for the treatment of type 2 diabetes, Cyramza for the treatment of metastatic Estimated Glomerular Filteration Rate (EGFR)-mutated non-small cell lung cancer, and tauvid for individuals diagnosed with Alzheimer's disease.

Key features of the study:
  • This report provides an in-depth analysis of the global active pharmaceutical ingredients (API) market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global active pharmaceutical ingredients (API) market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies.
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Dr. Reddy’s Laboratories Ltd., Novartis AG, Mylan N.V., Amneal Pharmaceuticals LLC, Lonza Group, Lupin Limited, Fresenius Kabi, Hikma Pharmaceuticals, Cipla Limited, Glenmark Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Endo International plc, Aurobindo Pharma Limited, Apotex Inc, Taro Pharmaceutical Industries Ltd, Stada Arzneimittel AG, Krka Pharmaceuticals, CordenPharma International, Evonik Industries AG, and Biological E. Limited.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global active pharmaceutical ingredients (API) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global active pharmaceutical ingredients (API) market.
Active Pharmaceutical Ingredients (API) Market Detailed Segmentation:
  • By Product Type:
  • Low Potent APIs
  • High Potent APIs
  • By Molecular Type:
  • Small Molecules
  • Large Molecules
  • By Formulation:
  • Oral
  • Topical
  • Injectables
  • Drops
  • By Application:
  • Diabetes
  • Oncology
  • Cardiovascular
  • CNS
  • Analgesics
  • Ophthalmic
  • Respiratory
  • Dermatology
  • Others
  • By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles
  • Teva Pharmaceutical Industries Ltd
  • Pfizer, Inc.
  • Reddy’s Laboratories Ltd
  • Novartis AG
  • Mylan N.V.
  • Amneal Pharmaceuticals LLC
  • Lonza Group
  • Lupin Limited
  • Fresenius Kabi
  • Hikma Pharmaceuticals
  • Cipla Limited
  • Glenmark Pharmaceuticals Limited
  • Sun Pharmaceutical Industries Ltd
  • Reddy’s Laboratories Ltd
  • Endo International plc
  • Aurobindo Pharma Limited
  • Apotex Inc.
  • Taro Pharmaceutical Industries Ltd
  • Stada Arzneimittel AG
  • Krka Pharmaceuticals
  • CordenPharma International
  • Evonik Industries AG
  • Biological E. Limited


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Molecular Type
Market Snippet, By Formulation
Market Snippet, By Application
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunity
Impact Analysis
Regulatory Scenario
Market Trends
API Patent Expiration
Production Capability Analysis
Mergers, Acquisitions and Collaboration Scenario
Key Developments
PEST Analysis
Investments & Funding
Production and Consumption Analysis
4. Global Active Pharmaceutical Ingredients (API) Market– COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Active Pharmaceutical Ingredients (API) Market, By Product Type, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Low Potent APIs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
High Potent APIs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
6. Global Active Pharmaceutical Ingredients (API) Market, By Molecular Type, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Small Molecules
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Large Molecules
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
7. Global Active Pharmaceutical Ingredients (API) Market, By Formulation, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Injectables
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Drops
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
8. Global Active Pharmaceutical Ingredients (API) Market, By Formulation, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Diabetes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Cardiovascular
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
CNS
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Bn)
Analgesics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Bn)
Ophthalmic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Bn)
Respiratory
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Bn)
Dermatology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Bn)
9. Global Active Pharmaceutical Ingredients (API) Market, By Region, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
North America
Introduction
Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 –2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018–2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Application, 2018–2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 –2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018–2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Application, 2018–2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 –2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018–2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By End User, 2018–2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 –2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018–2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Application, 2018–2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 –2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018–2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Application, 2018–2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 –2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018–2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Application, 2018–2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 –2030, (US$ Bn)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Company Profiles
Teva Pharmaceutical Industries Ltd
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Pfizer, Inc.
Dr. Reddy’s Laboratories Ltd
Novartis AG
Mylan N.V.
Amneal Pharmaceuticals LLC
Lonza Group
Lupin Limited
Fresenius Kabi
Hikma Pharmaceuticals
Cipla Limited
Glenmark Pharmaceuticals Limited
Sun Pharmaceutical Industries Ltd
Endo International plc
Aurobindo Pharma Limited
Apotex Inc.
Taro Pharmaceutical Industries Ltd
Stada Arzneimittel AG
Krka Pharmaceuticals
CordenPharma International
Evonik Industries AG
Biological E. Limited
11. Section
References
Research Methodology
About us and Sales Contact
*Browse 38 market data tables and 33 figures on “Global Active Pharmaceutical Ingredients (API) Market” – Global forecast to 2030

$4,500
$7,000
$10,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings